DE60130007D1 - Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion - Google Patents

Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Info

Publication number
DE60130007D1
DE60130007D1 DE60130007T DE60130007T DE60130007D1 DE 60130007 D1 DE60130007 D1 DE 60130007D1 DE 60130007 T DE60130007 T DE 60130007T DE 60130007 T DE60130007 T DE 60130007T DE 60130007 D1 DE60130007 D1 DE 60130007D1
Authority
DE
Germany
Prior art keywords
female sexual
relates
present
disorders
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130007T
Other languages
English (en)
Other versions
DE60130007T2 (de
Inventor
Martin G Crosby
Robert M Bennett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Semprae Laborations Inc (n D Gesd Staate Us
Original Assignee
Zestra Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zestra Laboratories Inc filed Critical Zestra Laboratories Inc
Application granted granted Critical
Publication of DE60130007D1 publication Critical patent/DE60130007D1/de
Publication of DE60130007T2 publication Critical patent/DE60130007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
DE60130007T 2000-06-27 2001-06-27 Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion Expired - Lifetime DE60130007T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21447200P 2000-06-27 2000-06-27
US214472P 2000-06-27
PCT/US2001/041141 WO2002000240A2 (en) 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response

Publications (2)

Publication Number Publication Date
DE60130007D1 true DE60130007D1 (de) 2007-09-27
DE60130007T2 DE60130007T2 (de) 2008-04-30

Family

ID=22799196

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130007T Expired - Lifetime DE60130007T2 (de) 2000-06-27 2001-06-27 Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Country Status (8)

Country Link
US (3) US6737084B2 (de)
EP (1) EP1328281B1 (de)
AT (1) ATE369868T1 (de)
AU (1) AU2001273636A1 (de)
CA (1) CA2417552C (de)
DE (1) DE60130007T2 (de)
ES (1) ES2291333T3 (de)
WO (1) WO2002000240A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US20060254597A1 (en) * 2000-12-14 2006-11-16 40J's Llc Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
GB0129987D0 (en) * 2001-12-14 2002-02-06 Zylepsis Ltd Skin compositions
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
US20060165735A1 (en) * 2002-06-18 2006-07-27 Abril Jesus R Stable emulsions of oils in aqueous solutions and methods for producing same
ITMI20030661A1 (it) * 2003-04-04 2004-10-05 Indena Spa Processo per la preparazione della ferutinina da piante del genere ferula
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
EP1699436A2 (de) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximon-formulierungen und ihre verwendung bei der behandlung von herzhypertrophy und herzinsuffizienz
US20050187507A1 (en) * 2004-01-08 2005-08-25 Reed Andre' L. Method and apparatus for removal of menses, reduction of menses interference during coitus, and enhancement of sexual pleasure
JP2007530563A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
US6949067B1 (en) * 2004-05-11 2005-09-27 Dann Jeffrey A Device and method for enhancing female sexual stimulation
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
GB0504547D0 (en) * 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
US20090041743A1 (en) * 2007-08-10 2009-02-12 Ma Te Lun Sperm-blocking agent composition with contraceptive effect
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness
US20090054498A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness
US20090054497A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Methods for attaining enhanced sexual wellness using anhydrous compositions
WO2011005438A2 (en) * 2009-06-22 2011-01-13 Donaldson Company, Inc. Filter element support assembly, quick installation system, and methods
US20110002966A1 (en) * 2009-07-01 2011-01-06 Alex Lovett Vaginal Suppository System and Method
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
KR102063003B1 (ko) 2011-05-13 2020-01-06 에이세러스 바이오파마 인크. 비강내 저 용량 강도 테스토스테론 겔 제형 및 성불감증 또는 성욕 감퇴 장애를 치료하기 위한 이의 용도
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
AU2014281768A1 (en) * 2013-06-19 2015-12-24 Access Business Group International Llc Plant-based inhibitors of ketohexokinase for the support of weight management
WO2015027201A1 (en) * 2013-08-22 2015-02-26 Baxco Pharmaceutical, Inc. Methods and compositions for enhancing female sexual wellness
CN103651359B (zh) * 2013-11-26 2015-09-23 武汉天惠生物工程有限公司 蛇床子素生物杀虫剂
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
CN104351181A (zh) * 2014-10-28 2015-02-18 山东中大药业有限公司 有效成分为大蒜素和蛇床子素的微囊悬浮剂
US20230041289A1 (en) * 2021-08-05 2023-02-09 Innovus Pharmaceuticals, Inc. Compositions and methods for enhancing or treating female sexual response

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231022B2 (de) * 1972-10-06 1977-08-12
US4096238A (en) 1974-12-23 1978-06-20 Alza Corporation Method for administering drug to the gastrointestinal tract
DE2602297B1 (de) 1976-01-22 1977-01-13 Merz & Co Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin
DE2654796A1 (de) 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4076854A (en) * 1977-03-03 1978-02-28 International Flavors & Fragrances Inc. Flavoring with a cyclohexadiene derivative
US4393871A (en) 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
EP0154756B2 (de) 1984-02-29 1996-10-23 Covex (S.A.) Vinpocetin-Citrate und Verfahren zu seiner Herstellung
US4692441A (en) 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
AU591196B2 (en) 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4989618A (en) 1988-02-24 1991-02-05 Vance Products Incorporated Device and method for intravaginal, barrier-type prevention of conception and infection
US5207232A (en) 1988-02-24 1993-05-04 Alfred A. Shihata Device and method for intravaginal, barrier-type prevention of conception and infection
US4858624A (en) 1988-02-24 1989-08-22 Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn Device and method for intravaginal, barrier-type prevention of conception and infection
NO179479C (no) 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
US4873078A (en) * 1988-04-22 1989-10-10 Plough, Inc. High-gloss, high-shine lipstick
JP2628346B2 (ja) * 1988-07-01 1997-07-09 株式会社トプコン メモリカード格納装置
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5177207A (en) 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US4999351A (en) 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5093336A (en) 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5145855A (en) 1989-07-06 1992-09-08 Hoechst Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
FR2650952B1 (fr) * 1989-08-17 1994-10-14 Lvmh Rech Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de coleus et procede pour sa preparation
EP0447962A1 (de) 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdane und Verfahren zu ihrer Herstellung
EP0448029B1 (de) 1990-03-23 1995-12-20 Nippon Kayaku Kabushiki Kaisha Neue pharmazeutische Verwendungen von Forskolin-Derivaten
US5350864A (en) 1990-05-03 1994-09-27 The United States Of America As Represented By The Department Of Health And Human Services Aminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivatives
US5077274A (en) * 1990-10-12 1991-12-31 International Flavors & Fragrances Inc. Bicyclo[10.2.0]tetradecan-13-one, fragrance use thereof, process for preparing same and dichlorinated intermediate used in said process
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
JPH07500264A (ja) 1991-10-10 1995-01-12 アルザ・コーポレーション 疎水性壁材料による浸透圧薬物投与デバイス
JPH05194179A (ja) * 1992-01-21 1993-08-03 Kanebo Ltd 皮膚化粧料
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5310556A (en) * 1993-06-09 1994-05-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition
CN1097311A (zh) 1993-07-14 1995-01-18 杨景信 用于性卫生保健用药妇春康软膏的制作方法
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
CN1104886A (zh) * 1994-01-06 1995-07-12 田华琴 祛斑、祛粉刺、祛皱护肤霜
US5731339A (en) 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
JPH08333266A (ja) * 1995-06-09 1996-12-17 Masatoshi Yamada 植物の活性成分を含有する医薬およびその用途
US6036977A (en) 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
CA2305394C (en) 1997-10-28 2006-12-12 Vivus, Incorporated Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
FR2777179A1 (fr) * 1998-04-09 1999-10-15 Lvmh Rech Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
US5891915A (en) 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
EP1113788A2 (de) * 1998-09-18 2001-07-11 Lavipharm Laboratories, Inc. Pflaster mit ätherischen ölen zur aromatherapie
JP2000119156A (ja) * 1998-10-14 2000-04-25 Kose Corp 皮膚外用剤
CN1237413A (zh) * 1999-05-06 1999-12-08 马宏 芦荟美容化妆品
AU5026600A (en) * 1999-05-18 2000-12-05 Procter & Gamble Company, The Methods of regulating the condition of mammalian keratinous tissue
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Also Published As

Publication number Publication date
ES2291333T3 (es) 2008-03-01
EP1328281A1 (de) 2003-07-23
US7875299B2 (en) 2011-01-25
WO2002000240A3 (en) 2003-09-25
CA2417552C (en) 2014-05-13
US20040202739A1 (en) 2004-10-14
DE60130007T2 (de) 2008-04-30
WO2002000240A2 (en) 2002-01-03
US8128972B2 (en) 2012-03-06
US6737084B2 (en) 2004-05-18
EP1328281B1 (de) 2007-08-15
AU2001273636A1 (en) 2002-01-08
ATE369868T1 (de) 2007-09-15
US20020034557A1 (en) 2002-03-21
CA2417552A1 (en) 2002-01-03
US20110117228A1 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
DE60130007D1 (de) Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
Quintans-Júnior et al. Antinociceptive activity and redox profile of the monoterpenes
Halder et al. Clove oil reverses learning and memory deficits in scopolamine-treated mice
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
DE60004374D1 (de) Zusammensetzung zur behandlung von infektionen bei mensch und tier
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
CL2004002050A1 (es) Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
BRPI0512864A (pt) composições e métodos para o tratamento de condições e desordens oculares
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
DE69714714T2 (de) Verwendung eines extraktes mindestens einer in vitro kultivierten labiate der gattung rosmarinarus in einer zusammensetzung
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
ME00595B (me) 2-okso-1-pirolidinski derivati, postupci za njihovo dobijanje i njihove primene
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
WO2006109898A8 (en) Antimicrobial composition containing natural extract, nano silver and natural essential oil
CL2004000647A1 (es) Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
AU7096201A (en) Phospholipid derivatives of valproic acid and mixtures thereof
EP2257161A4 (de) Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
Büyükafşar et al. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice
MXPA03008635A (es) Compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades.
WO2004087181A8 (de) WIRKSTOFFKOMBINATION VON ω3-FETTSÄUREHALTIGEN ÖLEN MIT POLYPHENOLHALTIGEN PFLANZENEXTRAKTEN UND DEREN VERWENDUNG
CN108949393A (zh) 一种添加植物活性成分的手工皂

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ZESTRA LABORATORIES,INC. (N. D. GES. D. STAATE, US

8327 Change in the person/name/address of the patent owner

Owner name: SEMPRAE LABORATIONS, INC. (N. D. GES.D. STAATE, US